William W. Freimuth

Nessuna posizione attualmente

Consumer Services

Health Technology

Precedenti posizioni note di William W. Freimuth

Società	Posizione	Inizio	Fine
Human Genome Sciences, Inc. Human Genome Sciences, Inc. Medical SpecialtiesHealth Technology Human Genome Sciences, Inc. is a biopharmaceutical company that exists to place new therapies into the hands of those battling serious disease. Its lead products include BENLYSTA for systemic lupus erythematosus and raxibacumab for inhalation anthrax. The firm's other products include, mapatumumab, darapladib, albiglutide, ZALBIN, HGS1036 and HGS1029. The company was founded by Alan G. Walton and William A. Haseltine in 1992 and is headquartered in Gaithersburg, MD.	Direttore Tecnico/Scientifico/R&S	15/04/2009	22/08/2011
	Corporate Officer/Principal	22/08/2011	01/10/2012
Pharmacia & Upjohn, Inc.	Corporate Officer/Principal	-	-

State University of New York at Buffalo	Doctorate Degree
Michigan State University	Doctorate Degree
University of Michigan	Undergraduate Degree

Distribuzione geografica

Stati Uniti

Posizioni

Doctorate Degree	2
Corporate Officer/Principal	2
Chief Tech/Sci/R&D Officer	1

Settori

Consumer Services	4
Health Technology	3

Posizioni ricoperte

Attive

Inattive

Società quotate in Borsa

Aziende private

Aziende private	2
Human Genome Sciences, Inc. Human Genome Sciences, Inc. Medical SpecialtiesHealth Technology Human Genome Sciences, Inc. is a biopharmaceutical company that exists to place new therapies into the hands of those battling serious disease. Its lead products include BENLYSTA for systemic lupus erythematosus and raxibacumab for inhalation anthrax. The firm's other products include, mapatumumab, darapladib, albiglutide, ZALBIN, HGS1036 and HGS1029. The company was founded by Alan G. Walton and William A. Haseltine in 1992 and is headquartered in Gaithersburg, MD.	Health Technology
Pharmacia & Upjohn, Inc.	Health Technology

Aziende private

Health Technology

Pharmacia & Upjohn, Inc.

Health Technology